At a glance
ClinicalIndex Comparison RecordN/ACompleted· 170 enrolled
Drug / intervention
VENOVO™ Venous Stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The BARD® VENOVO™ Venous Stent Study - A Prospective, Non-Randomized, Multi-Center, Single-Arm Study of the Treatment of Iliofemoral Occlusive Disease - an Assessment for Effectiveness and Safety (VERNACULAR)
In Brief
A clinical study evaluating VENOVO™ Venous Stent for May-Thurner Syndrome and 3 related conditions. Completed, enrolled 170 participants across 21 sites in 7 countries.
Detailed Summary
The BARD® Venovo™ Venous Stent Study is a non-randomized clinical study intended to collect confirmatory evidence of the safety and effectiveness of the Venous Stent for the treatment of iliofemoral occlusive disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMay-Thurner Syndrome, Peripheral Vascular Disease, Venous Disease, Iliofemoral Occlusive Disease
CountriesAustralia, Germany, Ireland, Netherlands, Spain, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 2016
Enrollment StartJun 2016
Primary CompletionJun 2018
Study CompletionOct 2020
TodayJul 2026
First PostedJan 14, 2016
Enrollment StartJun 15, 2016
Primary CompletionJun 19, 2018
Study CompletionOct 30, 2020
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 10.5 years ago
Interventions
VENOVO™ Venous Stentdevice
VENOVO™ Venous stent placement